Cefalexin (1St Gen) Capsules And Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules and Tablets
Available Strengths: 250 mg, 500 mg
Reference Brands: Keflex(US & EU)
Category:
Antibiotics
Cephalexin inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against skin, respiratory, and urinary tract infections. Benefits include broad-spectrum activity, rapid bacterial eradication, safety, and oral convenience, making it a reliable choice for outpatient treatment of common bacterial infections.
Cefalexin (1st Gen) Capsules and tablets is available in Oral Capsules and Tablets
and strengths such as 250 mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cefalexin (1st Gen) Capsules and tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefalexin (1st Gen) Capsules and tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cephalexin oral capsules and tablets are approved across the EU and US for treating bacterial infections such as skin, respiratory, and urinary tract infections. In the EU, brands like Keflex and generic formulations are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generic options readily available. Both regions require detailed dossiers including clinical trial results, quality control, and pharmacovigilance plans for initial approval and safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access, ensuring adherence to European and US standards for safe, effective use.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing